By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its fourth-quarter revenues increased 15 percent, or 6 percent organically, over the fourth quarter of 2010.

The Waltham, Mass.-based analytical tools firm brought in total revenues of $540.2 million for the three-month period ended Jan. 1, 2012, compared to $470 million for the fourth quarter of 2010. It beat analysts' consensus estimate for revenues of $537.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.